Cobra provides a comprehensive biologics and pharmaceuticals service offering, with multi-functional and experienced project teams nurturing customers’ DNA, Viral Vector and Microbiota products from pre-clinical through to clinical and commercial manufacture within GMP approved facilities.
Cobra is undertaking a multi-phase augmentation of its plasmid DNA services as a continuation of its Advanced Therapy expansion project Cobra...
Find Out More
In January 2020, following the completion of a successful acquisition process, Cobra Biologics became part of the Cognate Bioservices family. In the...
Find Out More
Providing large scale manufacturing capacity for AZD1222
Find Out More
Speak to a member of our expert team and arrange to take a tour of our GMP facilities in the UK and Sweden.
